Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform

Published: Thursday, April 03, 2014
Last Updated: Thursday, April 03, 2014
Bookmark and Share
Expansion to identify novel biomarkers predictive of cancer outcomes.

Cancer Genetics, Inc. and BioDiscovery, Inc. have announced expansion of the Nexus Copy Number Discovery platform in CGI research to uncover novel biomarkers which are predictive of cancer outcomes.

“Cancer Genetics has been able to leverage the Nexus Copy Number platform’s unique ability to quickly digest large data sets to uncover correlations between genomic events and clinical factors in their discovery efforts,” says Louis J. Culot, Vice President of Business Development and Marketing at BioDiscovery. “Cancer Genetics is an emerging leader in DNA cancer diagnostics. We are excited about the opportunity to play a role in the work being done and the impact that work is having on improving patient outcomes.”

“The Nexus Copy Number product is one of the primary analytic and collaboration tools for CGI’s R&D platform” says Jane Houldsworth, PhD, Vice President of Research and Development at CGI, “allowing our scientists to quickly mine complex data sets for underlying diagnostic and prognostic markers.”

CGI expects to utilize the many new features in Nexus Copy Number version 7.5, such as the ability to automatically classify samples with particular genomic aberrations, and plans to take advantage of the NGS support in the updated version.

According to CGI, the team at BioDiscovery has been highly responsive to scientists’ needs, accelerating research and development.

BioDiscovery Nexus Copy Number software offers simple yet powerful tools for copy number and sequence variation (CNV) analysis and visualization from microarrays and next generation sequencing (NGS), for analysis of complex data such as solid tumor samples and complex constitutional disease.

The scientist-driven software embeds powerful statistical tools designed specifically for the end-user, allowing rapid detection of chromosomal aberrations and identification of affected pathways.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioDiscovery Awarded National Institutes of Health SBIR Grant
SBIR Phase I grant to improve the copy number variation data from TCGA.
Thursday, July 10, 2014
N-of-One and BioDiscovery Partner
Partnership equips laboratories and oncologists with a foundation for genomic data analysis through to therapeutic options.
Tuesday, March 25, 2014
Cancer Centers Renew and Expand BioDiscovery’s Nexus Copy Number Software Licenses
BioDiscovery announces a number of license renewals and expansions of its Nexus Copy Number product at leading cancer research centers.
Wednesday, December 16, 2009
Fox Chase Cancer Center Adopts Nexus Copy Number and Nexus Expression
The center's Keystone Program in Blood Cell Development and Cancer gains a site license for two bioinformatics software programs from BioDiscovery.
Wednesday, February 11, 2009
Scientific News
Improving Crop Efficiency with CRISPR
New study of CRISPR-Cas9 technology from Virginia Tech shows potential to improve crop efficiency.
Gene Therapy Technique May Help Prevent Cancer Metastasis
Gene-regulating RNA molecules could help treat early-stage breast cancer tumors before they spread.
Space Research Fighting Cancer
JPL and National Cancer Institute renew Big Data partnership that 'learns' data similarities.
First Accurate Simulation of a Virus Invading a Cell
For the first time, scientists know what happens to a virus’ shape when it invades a host cell.Understanding how the virus shape specifically changes could lead to more effective anti-viral therapies.
Manipulation of Liquid Crystals Could Help Control Drug-Delivery Process
Computer modeling, real-world testing yields new method.
A New Approach for Deciphering Complex Immune Responses
Study seeks to establish the parameters that characterize the immune system of healthy individuals and its natural variability.
Infectious Prion Structure Shines Light on BSE
Prion research useing electron cryomicroscopy technology identified the structure of the infectious prion protein that causes BSE.
Vaccination Strategies Coax HIV-Neutralizing Antibody Production
New approaches to encourage the human immune system to produce HIV-blocking antibodies have been successful in mice.
Sequencing Soviet Anthrax
Next-gen genomic analysis has generated an anthrax genome sequence formerly from the USSR’s biological weapons program.
Closer to ‘Flesh-Eating’ Bacteria Vaccine
Patterns uncovered in the outer protein coat of group A Strep could lead to a vaccine againt the bacteria.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!